GlassScriptPhysician profile
Amanda Nichole Lawrence
NPI 1295026631
$2,585.96
in general payments reported to CMS, 2019-2025
20 companies · $734 in 2025
The $734 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $494 · 2022: $302 · 2023: $759 · 2024: $298 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432 · Education: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.53 |
| Education | $358.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $595.70 | 2021-2025 | Tremfya |
| Abbvie INC. | $539.16 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $361.59 | 2021-2025 | Absorica Ld, Ilumya |
| Ferring Pharmaceuticals INC. | $265.42 | 2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $215.21 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $105.92 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $90.82 | 2021-2024 | Ebglyss, Taltz, Zepbound |
| Genzyme Corporation | $64.98 | 2021-2025 | |
| Leo Pharma INC. | $62.16 | 2023 | Adbry |
| Biofrontera INC. | $57.93 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Pfizer INC. | $41.00 | 2025 | |
| Dermavant Sciences, INC. | $35.82 | 2023 | Vtama |
| Amgen INC. | $28.53 | 2024 | Otezla |
| Incyte Corporation | $26.82 | 2023 | Opzelura |
| Ucb, INC. | $19.63 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.86 | 2021 | |
| Arcutis Biotherapeutics, INC. | $18.81 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $16.56 | 2021 | |
| Journey Medical Corporation | $14.98 | 2022 | |
| Organon LLC | $6.06 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.